Ceftriaxone treatment for neuronal deficits: A histological and MEMRI study in a Rat model of dementia with Lewy bodies

Ying Jui Ho; Jun Cheng Weng; Chih Li Lin; Mei Shiuan Shen; Hsin Hua Li; Wen Chieh Liao; Nu Man Tsai; Ching Sui Hung; Te Jen Lai; I. Yen Lee

doi:10.1155/2018/4618716

Ceftriaxone treatment for neuronal deficits: A histological and MEMRI study in a Rat model of dementia with Lewy bodies

Ying Jui Ho^*, Jun Cheng Weng, Chih Li Lin, Mei Shiuan Shen, Hsin Hua Li, Wen Chieh Liao, Nu Man Tsai, Ching Sui Hung^*, Te Jen Lai^*, I. Yen Lee^*

^*此作品的通信作者

醫學影像暨放射科學系(含學碩博士班)

研究成果: 期刊稿件 › 文章 › 同行評審

11 引文斯高帕斯（Scopus）

摘要

Dementia with Lewy bodies (DLB) is characterized by neuronal deficits and α-synuclein inclusions in the brain. Ceftriaxone (CEF), a β-lactam antibiotic, has been suggested as a therapeutic agent in several neurodegenerative disorders for its abilities to counteract glutamate-mediated toxicity and to block α-synuclein polymerization. By using manganese-enhanced magnetic resonance imaging (MEMRI) and immunohistochemistry, we measured the effects of CEF on neuronal activity and α-synuclein accumulation in the brain in a DLB rat model. The data showed that CEF corrected neuronal density and activity in the hippocampal CA1 area, suppressed hyperactivity in the subthalamic nucleus, and reduced α-synuclein accumulation, indicating that CEF is a potential agent in the treatment of DLB.

原文	英語
文章編號	4618716
期刊	Behavioural Neurology
卷	2018
DOIs	https://doi.org/10.1155/2018/4618716
出版狀態	已出版 - 2018

文獻附註

Publisher Copyright:
Copyright © 2018 Ying-Jui Ho et al.

存取文件

10.1155/2018/4618716

其它文件與鏈接

Link to publication in Scopus

引用此

@article{599c04af7645400a859ed8a01539393f,

title = "Ceftriaxone treatment for neuronal deficits: A histological and MEMRI study in a Rat model of dementia with Lewy bodies",

abstract = "Dementia with Lewy bodies (DLB) is characterized by neuronal deficits and α-synuclein inclusions in the brain. Ceftriaxone (CEF), a β-lactam antibiotic, has been suggested as a therapeutic agent in several neurodegenerative disorders for its abilities to counteract glutamate-mediated toxicity and to block α-synuclein polymerization. By using manganese-enhanced magnetic resonance imaging (MEMRI) and immunohistochemistry, we measured the effects of CEF on neuronal activity and α-synuclein accumulation in the brain in a DLB rat model. The data showed that CEF corrected neuronal density and activity in the hippocampal CA1 area, suppressed hyperactivity in the subthalamic nucleus, and reduced α-synuclein accumulation, indicating that CEF is a potential agent in the treatment of DLB.",

author = "Ho, {Ying Jui} and Weng, {Jun Cheng} and Lin, {Chih Li} and Shen, {Mei Shiuan} and Li, {Hsin Hua} and Liao, {Wen Chieh} and Tsai, {Nu Man} and Hung, {Ching Sui} and Lai, {Te Jen} and Lee, {I. Yen}",

note = "Publisher Copyright: Copyright {\textcopyright} 2018 Ying-Jui Ho et al.",

year = "2018",

doi = "10.1155/2018/4618716",

language = "英语",

volume = "2018",

journal = "Behavioural Neurology",

issn = "0953-4180",

publisher = "John Wiley and Sons Ltd",

}

TY - JOUR

T1 - Ceftriaxone treatment for neuronal deficits

T2 - A histological and MEMRI study in a Rat model of dementia with Lewy bodies

AU - Ho, Ying Jui

AU - Weng, Jun Cheng

AU - Lin, Chih Li

AU - Shen, Mei Shiuan

AU - Li, Hsin Hua

AU - Liao, Wen Chieh

AU - Tsai, Nu Man

AU - Hung, Ching Sui

AU - Lai, Te Jen

AU - Lee, I. Yen

PY - 2018

Y1 - 2018

N2 - Dementia with Lewy bodies (DLB) is characterized by neuronal deficits and α-synuclein inclusions in the brain. Ceftriaxone (CEF), a β-lactam antibiotic, has been suggested as a therapeutic agent in several neurodegenerative disorders for its abilities to counteract glutamate-mediated toxicity and to block α-synuclein polymerization. By using manganese-enhanced magnetic resonance imaging (MEMRI) and immunohistochemistry, we measured the effects of CEF on neuronal activity and α-synuclein accumulation in the brain in a DLB rat model. The data showed that CEF corrected neuronal density and activity in the hippocampal CA1 area, suppressed hyperactivity in the subthalamic nucleus, and reduced α-synuclein accumulation, indicating that CEF is a potential agent in the treatment of DLB.

AB - Dementia with Lewy bodies (DLB) is characterized by neuronal deficits and α-synuclein inclusions in the brain. Ceftriaxone (CEF), a β-lactam antibiotic, has been suggested as a therapeutic agent in several neurodegenerative disorders for its abilities to counteract glutamate-mediated toxicity and to block α-synuclein polymerization. By using manganese-enhanced magnetic resonance imaging (MEMRI) and immunohistochemistry, we measured the effects of CEF on neuronal activity and α-synuclein accumulation in the brain in a DLB rat model. The data showed that CEF corrected neuronal density and activity in the hippocampal CA1 area, suppressed hyperactivity in the subthalamic nucleus, and reduced α-synuclein accumulation, indicating that CEF is a potential agent in the treatment of DLB.

UR - http://www.scopus.com/inward/record.url?scp=85054991548&partnerID=8YFLogxK

U2 - 10.1155/2018/4618716

DO - 10.1155/2018/4618716

M3 - 文章

C2 - 30154934

AN - SCOPUS:85054991548

SN - 0953-4180

VL - 2018

JO - Behavioural Neurology

JF - Behavioural Neurology

M1 - 4618716

ER -

Ceftriaxone treatment for neuronal deficits: A histological and MEMRI study in a Rat model of dementia with Lewy bodies

摘要

文獻附註

存取文件

其它文件與鏈接

指紋

引用此